INMB - INmune Bio - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INMB is currently covered by 1 analysts with an average price target of $9. This is a potential upside of $7.66 (305.41%) from yesterday's end of day stock price of $2.22.

INmune Bio's activity chart (see below) currently has 17 price targets and 20 ratings on display. The stock rating distribution of INMB is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.93% with an average time for these price targets to be met of 128.57 days.

Highest price target for INMB is $9, Lowest price target is $9, average price target is $9.

Most recent stock forecast was given by from LUCID CAPITAL on 11-Mar-2026. First documented stock forecast 19-Mar-2019.

Currently out of the existing stock ratings of INMB, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 11-Mar-2026

$9

$7.58 (533.80%)

$2

6 months 2 days ago
(11-Mar-2026)

1/2 (50%)

$7.58 (533.80%)

64

Hold Since 04-Aug-2025

$23

1 years 1 months 9 days ago
(04-Aug-2025)

0/2 (0%)

$15.19 (194.49%)

Buy Since 19-Mar-2019

$8

$6.58 (463.38%)

$30

1 years 2 months 11 days ago
(02-Jul-2025)

1/4 (25%)

$5.64 (238.98%)

483

Buy Since 22-Aug-2024

$0.6

$-0.82 (-57.75%)

$23

1 years 2 months 12 days ago
(01-Jul-2025)

0/5 (0%)

$-1.49 (-71.29%)

Buy Since 01-Sep-2020

$21

1 years 2 months 12 days ago
(01-Jul-2025)

1/2 (50%)

$12.98 (161.85%)

134

Show more analysts

Please expand the browser size to see the chart

What is INMB (INmune Bio) average time for price targets to be met?

On average it took 129 days for the stock forecasts to be reached, with an average price target met ratio of 33.93%.

Which analyst most recently updated their price target on INMB (INmune Bio)?

Which analyst has the most public recommendations on INMB (INmune Bio)?

has 0 price targets and 0 ratings on INMB

Which analyst is the currently most bullish on INMB (INmune Bio)?

Chad Mabry with the highest potential upside of $32.88

Which analyst is the currently most reserved on INMB (INmune Bio)?

George Farmer with the lowest potential downside of -$1.62

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?